ObjectiveTo define accurate and useful predictors of common bile duct stones (CBDS).
Summary Background DataThe ability to predict CBDS with noninvasive tests can avoid unnecessary, costly, or risky procedures.
MethodsAll patients referred for examination for CBDS by endoscopic ultrasonography (EUS) from 1993-1996 were prospectively entered in a database. In a first sample selected randomly from the whole population, predictors of CBDS were determined by univariate analysis and logistic regression. Predictors were subsequently tested in that sample and in the rest of the population. A separate analysis was done for patients planned for cholecystectomy.
ResultsEight hundred and eighty patients (328 men, 552 women), aged 57.8 ± 17 years (range 16-94), were included. The prevalence of CBDS was 18.8%. Age, serum levels of bilirubin, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transferase (GGT), and alkaline phosphatase, and the existence of jaundice and fever, a dilated bile duct, and a pathologic gallbladder were found to be associated with CBDS. Logistic regression was undertaken separately for patients younger than 70 years (predictors: GGT >7xnormal; pathologic gallbladder; dilated bile duct) and older than 70 years (predictors: GGT >7xnormal; fever > 380C; dilated bile duct). Odds ratios were 3 to 6.7. The model was satisfactorily applicable to the second sample; age <70 years: x2 = 3.3 (NS); age >70 years: x2 = 3.8 (NS). In patients younger than age 70 and planned for cholecystectomy, the combination of the level of GGT and dilated bile duct predicted CBDS accurately.
ConclusionsA simple screening of patients at risk for CBDS can be achieved with three predictive criteria adapted for the patient's age.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.